Special Issue "Bioactive Compounds for Metabolic Syndrome and Type 2 Diabetes-II"
Deadline for manuscript submissions: closed (29 February 2020).
Interests: dyslipidemia; atherosclerosis; echocardiography, oxidative stress; cardioprotection; type 2 diabetes; bioactive compounds; chronic diseases; nutraceuticals
Special Issues and Collections in MDPI journals
Metabolic Syndrome and Type 2 Diabetes are the major causes of morbidity and mortality in the elderly, with an increasing prevalence worldwide. These disorders cause micro-and macrovascular damage, leading to consequences, such as CAD, ischemia, heart failure, stroke, neuronal disturbances, reproductive and joint diseases, and other syndromes characterized by dysregulated inflammatory processes, and degradation of tissue function. Despite numerous recommendations emphasizing lifestyle changes, pharmacotherapy is also essential in the prevention and treatment of these syndromes, especially in more severe or chronic cases.
Bioactive compounds (phytonutrients or functional foods) have been defined as the extra nutritional constituents that are derived from natural products in small quantities. These molecules are mainly phytochemicals that can modulate metabolic processes, resulting in the promotion of better health. The bioaccessibility and bioavailability of each bioactive compound differs greatly, since several bioactive plant compounds are produced as secondary metabolites that are not essential for the daily functioning of the plant (such as growth), but play a significant role in competition, defense, attraction and signaling. Bioactive compounds in the plants can be specified as secondary plant metabolites eliciting pharmacological or toxicological effects in humans and animals. They include various molecules such as flavonoids, carotenoids, carnitine, choline, coenzyme Q, creatine, dithiolthiones, phytosterols, polysaccharides, phytoestrogens, glucosinolates, polyphenols, anthocyanins, prebiotics, and taurine.
This special issue aims to bring together food chemistry, food technology (with analysis or characterization of natural compounds) in medical interest and nutraceutical researches (for diet therapy and cosmetics) to identify and discuss cutting-edge research on novel ways in the treatment of Metabolic Syndrome and Type 2 Diabetes.
Dr. Béla Juhász
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Metabolic Syndrome
- Cardiovascular Diseases
- Insulin Resistance
- Bioactive Compounds
- Natural Products
- Food Chemistry